Skip to search formSkip to main contentSkip to account menu

EM 652

Known as: EM-652 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
EM-652 (acolbifene) analogs have been synthesized as selective estrogen receptor modulators. Substitution on the nitrogen atom of… 
Highly Cited
2003
Highly Cited
2003
OBJECTIVE EM-652 is a pure antiestrogen in human breast and uterine cancer cells that also reduces bone loss and plasma lipid… 
2002
2002
EM‐652 exerts pure antiestrogenic activity in the mammary gland and endometrium, while tamoxifen, the antiestrogen most widely… 
Review
2001
Review
2001
A new understanding of the endocrinology of menopause is that women, at menopause, are not only lacking estrogens resulting from… 
Review
1999
Review
1999
1998
1998
Highly Cited
1998
Highly Cited
1998
Estrogens act as potent mitogens in a large number of breast cancers, and the use of estrogen receptor (ER) antagonists is… 
Highly Cited
1997
Highly Cited
1997
Although temporary benefits of tamoxifen therapy are observed in up to 40% of women with breast cancer, this compound, which is…